|
Astra
|
Zeneca
|
| 1955 |
Astra AB signs agency contract with Fujisawa Pharmaceutical Co., Ltd. In conjunction with launch of Xylocaine in Japan |
|
| 1959 |
|
ICI UK concludes import and sales agreement with Sumitomo Chemical Co., Ltd. |
| 1974 |
|
ICI-Pharma established |
| 1975 |
Fujisawa-Astra, Ltd. established |
|
| 1985 |
|
ICI-Pharma Manufacturing Ltd. established |
| 1987 |
|
Sanda Plant begins operation |
| 1993 |
|
Company names changed from ICI-Pharma Ltd. And ICI-Pharma Manufacturing Ltd. To Zeneca Yakuhin K.K. and Zeneca K.K., respectively |
| 1994 |
Astra AB increases holding in Fujisawa-Astra to 90% and gains management rights |
|
| 1995 |
Company name changed to Astra Japan K.K. |
Self-distribution started |
| 1997 |
Maihara Plant and Distribution Center begin operation |
|
| 1998 |
Self-distribution started |
|
| AstraZeneca |
| 2000 |
January 1, 2000
Astra Japan Ltd. and Zeneca K.K. merge to form AstraZeneca K.K.
Bruno Angelici appointed President of AstraZeneca K.K.
October 1, 2000
AstraZeneca K.K. and Zeneca Yakuhin K.K. merge |
| 2001 |
February 1, 2001
Martin Wright appointed President of AstraZeneca K.K. |
| 2004 |
December 3, 2004
Masuhiro Kato appointed President of AstraZeneca K.K. |
| 2011 |
September 1, 2011
Paul Hudson appointed President of AstraZeneca K.K. |
